Related Experiment Video
Updated: Jan 17, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Promising treatment biomarkers in asthma
Barbara Bonnesen1, Jens-Ulrik S Jensen1,2, Alexander G Mathioudakis3,4
1Department of Medicine, Section of Respiratory Medicine, Herlev-Gentofte Hospital, Hellerup, Denmark.
Asthma classification has evolved from environmental factors to precision medicine. Biomarkers are key to identifying specific asthma phenotypes and guiding targeted treatments for better patient outcomes.
Area of Science:
- Pulmonology
- Immunology
- Genetics
Background:
- Asthma is a complex respiratory disease with significant heterogeneity.
- Traditional classification methods based on allergens, demographics, and lung function have limitations.
Purpose of the Study:
- To review the evolution of asthma classification.
- To highlight the role of biomarkers in identifying asthma phenotypes and endotypes.
- To discuss the application of precision medicine in asthma management.
Main Methods:
- Literature review of asthma classification systems.
- Focus on recent advances in biomarker discovery for asthma.
- Analysis of precision medicine approaches in asthma treatment.
Main Results:
- Asthma classification has shifted towards a more precise, biomarker-driven approach.
- Biomarkers offer insights into the distinct pathophysiological pathways of asthma.
- Precision medicine enables tailored treatment strategies based on individual patient profiles.
Conclusions:
- Biomarker identification is crucial for accurate asthma phenotyping and endotyping.
- Precision medicine guided by biomarkers represents the future of effective asthma management.
- Targeted therapies based on biomarkers can improve treatment efficacy and patient prognosis.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...